Clara Allayous
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 26, 2024
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 18, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.
Journal: The British journal of dermatology
Published: July 17, 2024
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 02, 2024
Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Journal: Melanoma research
Published: December 23, 2023
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 20, 2023
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Journal: Clinical and translational medicine
Published: October 13, 2023
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase).
Journal: Frontiers in oncology
Published: June 29, 2023
Efficacy of ipilimumab 3 mg/kg following progression on low-dose ipilimumab in metastatic melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 11, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.
Journal: Current oncology (Toronto, Ont.)
Published: October 19, 2022
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
Journal: Journal of the American Academy of Dermatology
Published: September 01, 2022
Last Updated: 09/26/2026